ATE473995T1 - Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung - Google Patents

Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung

Info

Publication number
ATE473995T1
ATE473995T1 AT02028323T AT02028323T ATE473995T1 AT E473995 T1 ATE473995 T1 AT E473995T1 AT 02028323 T AT02028323 T AT 02028323T AT 02028323 T AT02028323 T AT 02028323T AT E473995 T1 ATE473995 T1 AT E473995T1
Authority
AT
Austria
Prior art keywords
angiotensin
analogue
wound healing
tissue recovery
analogs
Prior art date
Application number
AT02028323T
Other languages
English (en)
Inventor
Kathleen Elizabeth Rodgers
Gere Stodder Dizerega
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Application granted granted Critical
Publication of ATE473995T1 publication Critical patent/ATE473995T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02028323T 1993-09-24 1994-09-19 Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung ATE473995T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12637093A 1993-09-24 1993-09-24

Publications (1)

Publication Number Publication Date
ATE473995T1 true ATE473995T1 (de) 2010-07-15

Family

ID=22424466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02028323T ATE473995T1 (de) 1993-09-24 1994-09-19 Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung

Country Status (9)

Country Link
US (1) US5716935A (de)
EP (2) EP1333034B1 (de)
JP (1) JPH09503205A (de)
AT (1) ATE473995T1 (de)
AU (1) AU697504B2 (de)
CA (1) CA2172494A1 (de)
DE (1) DE69435301D1 (de)
WO (1) WO1995008565A1 (de)
ZA (1) ZA947337B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902790A (en) * 1995-10-03 1999-05-11 Cytran, Inc. Pharmaceutical angiostatic dipeptide compositions and method of use thereof
US5955430A (en) 1993-09-24 1999-09-21 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
AU758319B2 (en) * 1994-11-14 2003-03-20 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
US5834432A (en) * 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US6110895A (en) * 1996-12-16 2000-08-29 University Of Southern California Method of promoting healing in skin grafts
US6335195B1 (en) 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
WO1998033813A2 (en) * 1997-02-04 1998-08-06 University Of Southern California Method for accelerating healing of thermal injuries
US6248587B1 (en) 1997-11-26 2001-06-19 University Of Southern Cailfornia Method for promoting mesenchymal stem and lineage-specific cell proliferation
AU755225B2 (en) * 1997-12-12 2002-12-05 University Of Southern California Wound healing compositions
WO1999040106A2 (en) 1998-02-09 1999-08-12 University Of Southern California Use of angiotensin analogues for promoting erythropoiesis
US6455500B1 (en) 1998-03-10 2002-09-24 University Of Southern California Radiation therapy methods
US7173011B2 (en) 2000-11-20 2007-02-06 University Of Southern California Radiation therapy methods
CA2323237C (en) * 1998-03-10 2009-05-19 University Of Southern California Improved radiation therapy methods
AU3077299A (en) 1998-03-11 1999-09-27 University Of Southern California Method of promoting production of living tissue equivalents
US6762167B1 (en) 1998-05-11 2004-07-13 University Of Southern California Methods for treating a patient undergoing chemotherapy
EP1073453B1 (de) * 1998-05-11 2005-04-13 University Of Southern California Verwendung von angiotensin analogen zur herstellung eines arzneimittels zur steigerung des ueberlebens der weissen blutzellen und mobilisierung von haematopoietischen stammzellen nach einer chemotherapeutischen behandlung
US6916783B2 (en) * 1998-07-13 2005-07-12 University Of Southern California Methods for accelerating bone and cartilage growth and repair
EP1094829B8 (de) 1998-07-13 2004-09-22 University Of Southern California Verfahren zur beschleunigung von knochen- und knorpelwachstum und reparatur
EP1105149A1 (de) 1998-08-13 2001-06-13 University Of Southern California Verfahren zur erhöhung der blutströmung zu ischämischen geweben
AU3734900A (en) * 1999-03-09 2000-09-28 University Of Southern California Method of promoting myocyte proliferation and myocardial tissue repair
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
ATE335496T1 (de) * 1999-03-23 2006-09-15 Univ Southern California Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung
US7338938B2 (en) 1999-05-10 2008-03-04 University Of Southern California Methods for treating a patient undergoing chemotherapy
US6821953B1 (en) * 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
US20020082222A1 (en) * 2000-11-30 2002-06-27 Shapira Nathan Andrew Treatments for neurogenetic disorders, impulse control disorder, and wound healing
WO2002087504A2 (en) * 2001-05-01 2002-11-07 University Of Southern California Methods for inhibiting tumor cell proliferation
WO2009114461A2 (en) * 2008-03-10 2009-09-17 University Of Southern California Angiotensin (1-7) dosage forms and uses thereof
EA026440B1 (ru) 2011-02-02 2017-04-28 Университи Оф Сатерн Калифорния Способ лечения диабетической язвы стопы
US8557958B1 (en) 2012-06-18 2013-10-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of diabetes
US8633158B1 (en) 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
EP3016670A4 (de) 2013-07-03 2017-01-18 The Arizona Board Of Regents On Behalf Of The University Of Arizona Verfahren zur behandlung von wahrnehmungsstörungen
US9333233B2 (en) 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke
US10183055B2 (en) 2014-07-21 2019-01-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
AU2015294371B2 (en) 2014-07-21 2018-02-01 The Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides and methods for using and producing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015629A (en) * 1989-06-26 1991-05-14 University Of Southern California Tissue repair

Also Published As

Publication number Publication date
AU7836494A (en) 1995-04-10
ZA947337B (en) 1995-05-10
EP0745091A4 (de) 1998-05-20
DE69435301D1 (de) 2010-08-26
EP1333034B1 (de) 2010-07-14
EP1333034A1 (de) 2003-08-06
AU697504B2 (en) 1998-10-08
US5716935A (en) 1998-02-10
WO1995008565A1 (en) 1995-03-30
CA2172494A1 (en) 1995-03-30
EP0745091A1 (de) 1996-12-04
JPH09503205A (ja) 1997-03-31

Similar Documents

Publication Publication Date Title
ATE473995T1 (de) Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung
DK0730465T3 (da) Anvendelse af angiotensin III og analoger dertil til vævsreparation
MX9703609A (es) Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
ATE378075T1 (de) Biologisch resorbierbare kalzium phosphate zement-zusammensetzungen
ATE88899T1 (de) Wundheilung und knochenregeneration.
DE3752112T2 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
DE69316013T2 (de) Verwendung von phosphinate zur behandlung der osteoporose
DE59407098D1 (de) Verwendung von diglycerinestern gegen unreine haut
ES2106031T3 (es) Una composicion comprendiendo un factor de crecimiento, su metodo de obtencion y uso.
IL124431A0 (en) Sulfur containing dl-tert-butylphenol compounds useful as anti-inflammatory agents
BR0109139B1 (pt) composiÇÕes farmacÊuticas incluindo alginatos
DE59000195D1 (de) Pharmazeutisches praeparat zur behandlung von lebererkrankungen.
DK0523406T3 (da) Anvendelse af tri-(n-butyl)-phosphat ved lavt pH i opløsninger af biologisk aktive proteiner til forøget virucid virkning
BR9002240A (pt) Processo para a preparacao de uma composicao conservada apropriada para aplicacao topica a pele e composicao
MX9709983A (es) El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos.
DK0569411T3 (da) Acylaminoalkylidenhydroxybiphosphonsyrer anvendelige til behandling af osteoartikulære sygdomme
JPS57126494A (en) Trifluoromethoxyphenyl-(di)thiophosphoric acid ester, manufacture and insecticide containing same as active component
CO5070608A1 (es) Metodo para aumentar la permeabilidad del tejido corneo humano
ATE73812T1 (de) Thionophosphonsaeureester.
DE69915852D1 (de) Lhrh-analoga zur behandlung der osteoporose
DE69509657D1 (de) Verwendung von benzothiophenen zur herstellung eines medikaments zur verminderung der narbenbildung bei der wundheilung
UA31714A (uk) Засіб для зовнішнього лікування гнійних ран і трофічних виразок

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties